D.E. Shaw & Co’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,365
Closed -$149K 4610
2025
Q4
$149K Sell
14,365
-11,254
-44% -$102K ﹤0.01% 4371
2025
Q3
$152K Buy
25,619
+290
+1% +$2.12K ﹤0.01% 4318
2025
Q2
$191K Sell
25,329
-6,165
-20% -$49.5K ﹤0.01% 4063
2025
Q1
$238K Sell
31,494
-17,438
-36% -$167K ﹤0.01% 3857
2024
Q4
$596K Sell
48,932
-10,308
-17% -$148K ﹤0.01% 3510
2024
Q3
$992K Sell
59,240
-153,208
-72% -$2.72M ﹤0.01% 3277
2024
Q2
$3.71M Buy
212,448
+150,827
+245% +$3.21M 0.01% 2087
2024
Q1
$1.05M Buy
61,621
+12,702
+26% +$196K ﹤0.01% 3064
2023
Q4
$498K Buy
48,919
+9,217
+23% +$81.7K ﹤0.01% 3514
2023
Q3
$359K Sell
39,702
-16,243
-29% -$169K ﹤0.01% 3544
2023
Q2
$602K Sell
55,945
-17,627
-24% -$187K ﹤0.01% 3345
2023
Q1
$753K Sell
73,572
-26,129
-26% -$288K ﹤0.01% 3345
2022
Q4
$1.05M Buy
99,701
+22,261
+29% +$270K ﹤0.01% 3411
2022
Q3
$993K Sell
77,440
-17,546
-18% -$236K ﹤0.01% 3600
2022
Q2
$1.22M Buy
+94,986
New +$1.08M ﹤0.01% 3494
2021
Q3
Sell
-60,319
Closed -$1.55M 4990
2021
Q2
$1.55M Sell
60,319
-3,714
-6% -$114K ﹤0.01% 3180
2021
Q1
$2.67M Buy
+64,033
New +$2.6M ﹤0.01% 2342

Other funds holding CGEM